Mandate

Vinge advises Orkla in connection with the acquisition of Zeelandia AB

Vinge has advised Orkla in connection with Orkla Food Ingredients AS’s acquisition of Zeelandia AB from Koninklijke Zeelandiaa Groep B.V.

Orkla is a leading actor of trademark and concept solutions for trading in convenience goods and large-scale catering institutions within the Nordic Region, Baltic Region, Central Europe and India. In 2018, the group’s turnover was NOK 41 billion and had approximately 18 500 employees. Orkla Food Ingredients is the largest actor within the bakery ingredients industry in the Nordic Region, and distributes products to 21 countries in total. The primary product categories are yeast, butter, plant‑based products, marzipan and margarine. Zeelandia AB’s product portfolio includes ingredients for all types of bread, buns, cakes and pastries as well as separating agents, balancing oils and food fillers, and is a strategic acquisition in order to strengthen Orkla’s position on the Nordic market. Following the acquisition, Zeelandia AB will change its name to Credin Sverige AB.

The acquisition is conditional upon the consent of the relevant competition authorities and other customary closing conditions.

Vinge’s team consisted of partners Peter Sundgren and Johan Karlsson together with, among others, associates Filip Öhrner, Christina Odengran, Isabelle Jengsell, Christoffer Nordin, Karin Virding, Lisa Ullman and project assistant Viktoria Owetz. Trine Osen Bergquist and Sebastian Örndahl provided competition law advice.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB.

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB. The final purchase price will be based on the outstanding loan volume in the portfolio as of closing date. As of March 2024, the outstanding loan volume in the portfolio amounted to approximately SEK 3.8 billion. The acquisition is subject to customary regulatory approvals.
April 22, 2024